Thermo Fisher Scientific TMO
NYSE TMO
$659.18 +10.75 (+1.66%)
As of: Sep 17, 2026 · 3:59 PM EDT

Thermo Fisher Scientific (TMO) Cash & Equivalents Growth (3y) (2012 - 2026)

Analysis

Thermo Fisher Scientific (TMO) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 9.06%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -20.26%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 9.77%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -12.51%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -8.42%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 13.60%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 9.85%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 10.32%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 15.53%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -31.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 9.06%
Mar 28, 2026 -2.23%
Dec 31, 2025 4.94%
Sep 27, 2025 -12.11%
Jun 28, 2025 34.33%
Mar 29, 2025 14.53%
Dec 31, 2024 -3.61%
Sep 28, 2024 -27.18%
Jun 29, 2024 0.24%
Mar 30, 2024 -0.50%
Dec 31, 2023 -7.86%
Sep 30, 2023 -6.56%
Jul 1, 2023 -18.64%
Apr 1, 2023 5.31%
Dec 31, 2022 52.59%
Oct 1, 2022 31.87%
Jul 2, 2022 -6.20%
Apr 2, 2022 35.51%
Dec 31, 2021 28.64%
Oct 2, 2021 122.08%